(1)
Nakashima, S.; Kakugawa, T.; Motomura, H.; Hirano, K.; Sasaki, E.; Nagata, Y.; Kinoshita, A.; Sakamoto, N.; Ishimatsu, Y.; Mukae, H.; Kohno, S. Development of Imatinibmesylate-Induced Interstitial Lung Disease 2 Weeks After Discontinuation of the Treatment: A Case Report. Multidiscip Respir Med 2012, 7. https://doi.org/10.4081/mrm.2012.635.